A new test reveals which patients with leukemia and other blood disorders are likely to respond to treatment for graft-versus-host disease that develops after a stem cell transplant.
James L. M. Ferrara MD, DSc
Advertisement
Articles by James L. M. Ferrara MD, DSc
Advertisement
Latest Updated Articles
New Test Could Guide More Precise Treatment of GVHDAugust 17th 2015
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
2
Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer
3
Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026
4
A global, randomized, double-blinded, Phase 3 trial of vorasidenib vs placebo in patients with grade 2 glioma with an IDH1/2 mutation (INDIGO): updated efficacy and safety
5